Literature DB >> 11171051

Localization of membrane-type 1 matrix metalloproteinase in caveolae membrane domains.

B Annabi1, M Lachambre, N Bousquet-Gagnon, M Pagé, D Gingras, R Béliveau.   

Abstract

Membrane-type 1 matrix metalloproteinase (MT1-MMP) is a membrane-associated MMP that has been recently reported to have a central role in tumour cell invasion. Here we report that both the native and overexpressed recombinant forms of MT1-MMP are highly enriched in low-density Triton X-100-insoluble membrane domains that contain the caveolar marker protein caveolin 1. Moreover, the MT1-MMP-dependent activation of proMMP-2 induced by concanavalin A and cytochalasin D was correlated with the processing of MT1-MMP to its proteolytically inactive 43 kDa fragment in U-87 glioblastoma and HT-1080 fibrosarcoma tumour cell lines; this processing was also preferentially observed within the caveolar fraction. Interestingly, whereas the expression of caveolin 1 had no effect on the MT1-MMP-dependent activation of proMMP-2, its co-expression with MT1-MMP antagonized the MT1-MMP-increased migratory potential of COS-7 cells. Taken together, our results provide evidence that MT1-MMP is preferentially compartmentalized and proteolytically processed in caveolae of cancer cells. The inhibition of MT1-MMP-dependent cell migration by caveolin 1 also suggests that the localization of MT1-MMP to caveolin-enriched domains might have an important function in the control of its enzymic activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11171051      PMCID: PMC1221600          DOI: 10.1042/0264-6021:3530547

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  28 in total

1.  Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion.

Authors:  H Nakahara; L Howard; E W Thompson; H Sato; M Seiki; Y Yeh; W T Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

Review 2.  Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane.

Authors:  T Okamoto; A Schlegel; P E Scherer; M P Lisanti
Journal:  J Biol Chem       Date:  1998-03-06       Impact factor: 5.157

3.  Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1-matrix metalloproteinase 1 (MT1-MMP).

Authors:  S Zucker; M Drews; C Conner; H D Foda; Y A DeClerck; K E Langley; W F Bahou; A J Docherty; J Cao
Journal:  J Biol Chem       Date:  1998-01-09       Impact factor: 5.157

4.  The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study.

Authors:  G S Butler; M J Butler; S J Atkinson; H Will; T Tamura; S Schade van Westrum; T Crabbe; J Clements; M P d'Ortho; G Murphy
Journal:  J Biol Chem       Date:  1998-01-09       Impact factor: 5.157

Review 5.  Membrane-type matrix metalloproteinases (MT-MMPs) in cell invasion.

Authors:  H Sato; Y Okada; M Seiki
Journal:  Thromb Haemost       Date:  1997-07       Impact factor: 5.249

Review 6.  Relating matrix metalloproteinase structure to function: why the "hemopexin" domain?

Authors:  G Murphy; V Knäuper
Journal:  Matrix Biol       Date:  1997-03       Impact factor: 11.583

7.  The C-terminal (haemopexin-like) domain structure of human gelatinase A (MMP2): structural implications for its function.

Authors:  U Gohlke; F X Gomis-Rüth; T Crabbe; G Murphy; A J Docherty; W Bode
Journal:  FEBS Lett       Date:  1996-01-08       Impact factor: 4.124

Review 8.  Matrix metalloproteinases: structures, evolution, and diversification.

Authors:  I Massova; L P Kotra; R Fridman; S Mobashery
Journal:  FASEB J       Date:  1998-09       Impact factor: 5.191

9.  Localization of RhoA GTPase to endothelial caveolae-enriched membrane domains.

Authors:  D Gingras; F Gauthier; S Lamy; R R Desrosiers; R Béliveau
Journal:  Biochem Biophys Res Commun       Date:  1998-06-29       Impact factor: 3.575

10.  Cellular activation of mesangial gelatinase A by cytochalasin D is accompanied by enhanced mRNA expression of both gelatinase A and its membrane-associated gelatinase A activator (MT-MMP).

Authors:  M Ailenberg; M Silverman
Journal:  Biochem J       Date:  1996-02-01       Impact factor: 3.857

View more
  35 in total

1.  Calmodulin inhibitors trigger the proteolytic processing of membrane type-1 matrix metalloproteinase, but not its shedding in glioblastoma cells.

Authors:  B Annabi; A Pilorget; N Bousquet-Gagnon; D Gingras; R Béliveau
Journal:  Biochem J       Date:  2001-10-15       Impact factor: 3.857

2.  Lung dysfunction causes systemic hypoxia in estrogen receptor beta knockout (ERbeta-/-) mice.

Authors:  Andrea Morani; Rodrigo P A Barros; Otabek Imamov; Kjell Hultenby; Anders Arner; Margaret Warner; Jan-Ake Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-24       Impact factor: 11.205

Review 3.  Extracellular matrix, junctional integrity and matrix metalloproteinase interactions in endothelial permeability regulation.

Authors:  J S Alexander; John W Elrod
Journal:  J Anat       Date:  2002-06       Impact factor: 2.610

Review 4.  Matrix-metalloproteinases as targets for controlled delivery in cancer: An analysis of upregulation and expression.

Authors:  Kyle J Isaacson; M Martin Jensen; Nithya B Subrahmanyam; Hamidreza Ghandehari
Journal:  J Control Release       Date:  2017-01-31       Impact factor: 9.776

5.  Mechanism of metastasis by membrane type 1-matrix metalloproteinase in hepatocellular carcinoma.

Authors:  Ying-Chi Ip; Siu-Tim Cheung; Ka-Ling Leung; Sheung-Tat Fan
Journal:  World J Gastroenterol       Date:  2005-10-28       Impact factor: 5.742

6.  Proteomics characterization of cell membrane blebs in human retinal pigment epithelium cells.

Authors:  Oscar Alcazar; Adam M Hawkridge; Timothy S Collier; Scott W Cousins; Sanjoy K Bhattacharya; David C Muddiman; Maria E Marin-Castano
Journal:  Mol Cell Proteomics       Date:  2009-06-29       Impact factor: 5.911

7.  Matrix metalloproteinase 13 mediates nitric oxide activation of endothelial cell migration.

Authors:  Esther López-Rivera; Tania R Lizarbe; Mónica Martínez-Moreno; José Miguel López-Novoa; Alicia Rodríguez-Barbero; José Rodrigo; Ana Patricia Fernández; Alberto Alvarez-Barrientos; Santiago Lamas; Carlos Zaragoza
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-22       Impact factor: 11.205

8.  Caveolae are a novel pathway for membrane-type 1 matrix metalloproteinase traffic in human endothelial cells.

Authors:  Beatriz G Gálvez; Salomón Matías-Román; María Yáñez-Mó; Miguel Vicente-Manzanares; Francisco Sánchez-Madrid; Alicia G Arroyo
Journal:  Mol Biol Cell       Date:  2003-12-02       Impact factor: 4.138

9.  Rat forming incisor requires a rigorous ECM remodeling modulated by MMP/RECK balance.

Authors:  Katiucia Batista Silva Paiva; Willian Fernando Zambuzzi; Thais Accorsi-Mendonça; Rumio Taga; Fabio Daumas Nunes; Mari Cleide Sogayar; José Mauro Granjeiro
Journal:  J Mol Histol       Date:  2009-10-17       Impact factor: 2.611

10.  Induction of tissue inhibitor of matrix metalloproteinase-2 by cholesterol depletion leads to the conversion of proMMP-2 into active MMP-2 in human dermal fibroblasts.

Authors:  Sangmin Kim; Jang-Hee Oh; Youngae Lee; Jeongyoon Lee; Kwang Hyun Cho; Jin Ho Chung
Journal:  Exp Mol Med       Date:  2010-01-31       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.